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Information on problem drug use is collected by the National Drug Treatment Reporting
System (NDTRS). The NDTRS is an epidemiological database on treated drug misuse. It was
established in 1990 in the Greater Dublin Area only. In 1995 it was extended to cover other
areas of the country, including the North Western Health Board (NWHB) area. The
objectives of the NDTRS are to provide reliable information on the number and
characteristics of people who are treated for problem drug use; and to examine trends and
patterns of problem drug use. It provides information relevant to the health consequences
and social implications of drug misuse and contributes to an understanding of the
epidemiology of drug misuse in Ireland. This series of papers presents data by regional
health board areas. 
NDTRS methodology
Background
Data on treated drug misuse are collected routinely by staff at drug treatment agencies
throughout Ireland. In the NWHB area data collection is co-ordinated by a Regional Co-ordinator.
Compliance with the NDTRS requires that a form be completed for each person who receives
treatment for problematic drug use. At national level, aggregated anonymous data are compiled
by the Drug Misuse Research Division (DMRD), Health Research Board (HRB). 
For the purpose of the NDTRS, treatment is broadly defined as ‘any activity which aims to ameliorate
the psychological, medical or social state of individuals who seek help for their drug problems’.
Treatment may therefore include non-medical (addiction counselling, group therapy, psychotherapy),
as well as medical interventions (detoxification, methadone substitution programmes).  
The main elements of the reporting system are: 
a) All Treatment Contacts – the reporting of all clients receiving treatment during a given year,
and 
b) First Treatment Contacts – the reporting of the sub-group of clients who have never previously
been treated for problem drug use.
In the case of the ‘all contact’ data there is a possibility of duplication in the database, for example,
where a person receives treatment at more than one centre. This is estimated to be small since the
introduction of the Misuse of Drugs Regulations in 1998, whereby precautions are taken to ensure
that treatment by way of medical prescription is available from one source only.  
Treatment as an indicator of drug misuse
Drug treatment data are viewed as an indirect indicator of drug misuse and are used at
national and European levels to provide information on the characteristics of clients
entering treatment, and patterns of drug misuse such as types of drugs used and
consumption behaviours. They are ‘valuable from a public health perspective to assess
needs, … and to plan and evaluate services’ (EMCDDA, 1998: 23). Information from the
NDTRS is made available to service providers and policy makers and forms an important
element in informing local and national drug policies. Based on NDTRS data a number of
local areas were targeted for special attention in 1996 (Ministerial Task Force, 1996).
Table 1a. Number of All Treatment Contacts* by treatment area and area of residence of clients,
1996-2000
Year Total treated in NWHB NWHB residents NWHB residents Others treated in Total NWHB residents
treated in NWHB treated elsewhere NWHB treated
1996 13 12 4 1 16
1997 17 17 4 0 21
1998 45 45 3 0 48
1999 39 37 3 2 40
2000 77 77 3** 0 80**
* Number of cases, as distinct from individuals, who received treatment for their problem drug use
** Provisional figures due to incomplete returns from the Eastern Regional Health Authority health boards
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The emphasis of drug policy in the NWHB area is on health promotion (http://www.nwhb.ie). The North
West Interagency Drug Group, which was established in 1995, ensures a co-ordinated response to the
problem of drug misuse in the region (North West Interagency Drug Group, 1999). The goal of the Health
Promotion Service is to reduce the harm caused by the misuse of alcohol and other drugs
(http://www.nwhb.ie). Drug strategies promote healthy lifestyles; and the implementation of drug prevention
programmes are encouraged and supported in schools and youth clubs throughout the area. Support is
provided to general practitioners involved in providing methadone treatment. A direct access service for
young people with drug problems is provided. 
Drug treatment services in the NWHB area, reporting to the NDTRS during 2000, were provided by 8
agencies: all are non-residential centres. The type of drug treatment provided/availed of was mainly
advice/counselling/support (N=72). The treatment provided to any one individual can be a combination of a
number of options. During 2000, as well as addiction counselling, 3 contacts received ‘medicament
free/psychosocial therapy’; 3 were involved in ‘social/occupational reintegration’ programmes; 4 underwent
detoxification; and 3 attended a drug substitution/maintenance programme.  
Extent of the problem
Treatment provision
Initially eleven areas, ten in Dublin and one in Cork, all of which were characterised by social and
economic disadvantage, were designated as Local Drug Task Force Areas (Ministerial Task Force, 1996).
There are now fourteen areas: twelve in Dublin; one in Cork; and one in Bray (Department of Tourism,
Sport & Recreation, 2001). Local Drug Task Forces were established with the aim of providing strategic
local responses in areas where drug misuse was a serious problem.
In the Government’s Building on Experience. National Drugs Strategy 2001-2008, the role of the NDTRS is
recognised in ensuring that the overall aims of the strategy are met. NDTRS data collection is one of the
actions identified and agreed by Government for implementation by health boards. It is stated that ‘all
treatment providers should co-operate in returning information on problem drug use to the DMRD of
the HRB’ (Department of Tourism, Sport & Recreation, 2001: 118). 
The emphasis of
drug policy in
the NWHB area
is on health
promotion
During 2000,
80 NWHB
residents
were treated
for problem
drug use
The number of drug users presenting for treatment2 in the NWHB area increased from 13 in 1996 to 77 in
2000.  This increase was probably due in part to improved service provision, and partly to an increase in
drug use. All those who received treatment in the NWHB area during 2000 (N=77) were from the
catchment area (Table 1a). A small number of people were treated elsewhere each year (N=3 in 2000). No
one from outside the catchment area was treated in the NWHB in 2000.
1 Counties Donegal, Leitrim and Sligo
2 The emphasis of this paper is on the illicit drug use of clients who received treatment between 1996 and 2000, in the catchment area covered
by the NWHB (Donegal, Leitrim and Sligo)
Table 1b. Number of First Treatment Contacts* by treatment area and area of residence of 
clients, 1996-2000
Year Total treated in NWHB NWHB residents NWHB residents Others treated in Total NWHB residents
treated in NWHB treated elsewhere NWHB treated
1996 6 6 3 0 9
1997 14 14 3 0 17
1998 29 29 0 0 29
1999 27 25 1 2 26
2000 60 60 2** 0 62**
* Number of people who received treatment for the first time ever
** Provisional figures due to incomplete returns from the Eastern Regional Health Authority health boards
Table 2a. Socio-demographic characteristics of All Treatment Contacts treated in the NWHB, 
1996-2000
Characteristics 1996 1997 1998 1999 2000
% Males : % Females 83:17 76:24 70:30 77:23 74:26
Mean age (years) 27 26 24 23 24
Modal age (years) 23 24 20 18, 19 21
% Under 18 years of age 15 13 14 5 16
% Living with parents/family 50 47 58 74 58
% Early school leavers* 0 8 3 12 10
% Still at school 30 15 14 4 18
% Employed 23 29 36 18 25
* Left school before the age of 15 years
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The typical client coming for treatment is male, in his early twenties and likely to be living in the family
home. There was a slight drop in the age of drug users over the period 1996 to 2000. The mean age for
all contacts was 24 years in 2000, younger by three years than in 1996; the modal age (the most
frequently occurring age) was 21 years in 2000 (Table 2a). The social conditions of clients fluctuated over
the five-year period 1996 to 2000. Around half live in the family home, except in 1999 when nearly
three-quarters were living with family. Very few clients had left school before the official school leaving
age of 15 years. Employment levels fluctuated, going from 23 percent in 1996 to 36 percent in 1998 and
dropping to 25 percent in 2000 (Table 2a). Despite improved economic conditions in the country there
was not, as in some other areas, a consistent increasing trend in employment levels among drug users in
the NWHB area. This is indicative of the social disadvantage of drug users and presents a challenge to
policy makers if social exclusion and marginalisation issues are to be addressed.       
Socio-demographic information
Most of those treated in the NWHB area each year were new clients (first contacts) – they were receiving
treatment for problem drug use for the first time. The number of first contacts increased from 6 in 1996
to 60 in 2000 (Table 1b).  
The majority of all contacts (78 percent) are new clients (first contacts), therefore there are no
remarkable differences in trends between first and all contacts (Table 2b).    
The typical client
coming for
treatment is
male, in his early
twenties and
likely to be living
in the family
home
Table 2b. Socio-demographic characteristics of First Treatment Contacts treated in the NWHB, 
1996-2000
Characteristics 1996 1997 1998 1999 2000
% Males : % Females 100:0 71:29 68:32 74:26 73:27
Mean age (years) 23 25 22 22 23
Modal age (years) --** --** 20 18 20, 21
% Under 18 years of age 17 15 17 7 18
% Living with parents/family 67 50 72 73 60
% Early school leavers* 0 0 0 5 8
% Still at school 40 20 17 5 19
% Employed 17 36 46 19 29
* Left school before the age of 15 years
** More than two modal ages identified
Table 3a. Main Drug of Misuse of All Treatment Contacts treated in the NWHB, 1996-2000   
Main Drug of 1996 1997 1998 1999 2000
Misuse N (%) N (%) N (%) N (%) N (%)
Opiates 1 (8) 2 (13) 10 (22) 6 (15) 5 (6)
Cocaine 1 (8) 0 (0) 0 (0) 0 (0) 0 (0)
Ecstasy 3 (23) 3 (19) 10 (22) 12 (31) 25 (32)
Amphetamines 0 (0) 1 (6) 0 (0) 0 (0) 2 (3)
Benzodiazepines 1 (8) 0 (0) 1 (2) 1 (3) 4 (5)
Volatile Inhalants 0 (0) 1 (6) 1 (2) 0 (0) 2 (3)
Cannabis 6 (46) 9 (56) 21 (47) 20 (51) 39 (51)
Other substances 1 (8) 0 (0) 2 (4) 0 (0) 0 (0)
Total 13 17* 45 39 77
* Percentages based on a valid N of 16
Table 3b. Main Drug of Misuse of First Treatment Contacts treated in the NWHB, 1996-2000 
Main Drug of 1996 1997 1998 1999 2000
Misuse N (%) N (%) N (%) N (%) N (%)
Opiates 0 (0) 1 (7) 1 (3) 3 (11) 0 (0)
Cocaine 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Ecstasy 2 (33) 3 (21) 8 (28) 11 (41) 20 (33)
Amphetamines 0 (0) 1 (7) 0 (0) 0 (0) 2 (3)
Benzodiazepines 0 (0) 0 (0) 0 (0) 0 (0) 4 (7)
Volatile Inhalants 0 (0) 1 (7) 1 (3) 0 (0) 2 (3)
Cannabis 3 (50) 8 (57) 18 (62) 13 (48) 32 (53)
Other substances 1 (17) 0 (0) 1 (3) 0 (0) 0 (0)
Total 6 14 29 27 60
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Information on the patterns of drug use, such as the types of drugs used, how they are taken, and whether
they are taken in combination with other drugs, can be useful in assessing and planning drug treatment
services. Drug use patterns in the NWHB area are similar to those in other regions of the country where
cannabis is the main drug causing problems and for which most people present for treatment (O’Brien, et
al.). Given that cannabis is smoked, this can have serious implications for the future health of a relatively
young population. Trends over the period 1996 to 2000 show that while the proportion of cannabis users
remained stable, at around a half, the number increased from 6 in 1996 to 39 in 2000 (Table 3a). Ecstasy
use increased over the five-year period from 23 percent (N=3) in 1996, to 32 percent (N=25) in 2000. The
number of opiate users fluctuated over the five-year period from 1 in 1996, to 10 in 1998, and to 5 in
2000; the proportion rose from 8 percent in 1996 to 22 percent in 1998 and fell to 6 percent in 2000.    
Problem drug use
As the majority (78 percent in 2000) of all contacts are new clients there is very little difference between
new clients and the overall group of all contacts (Table 3b).     
A closer scrutiny of opiate as a main drug of misuse reveals that heroin use is not presenting as a
problem in the NWHB area. Over the five-year period 1996 to 2000 the highest number of clients
presenting for treatment was 9, in 1998 (Table 4a).    
Trends show that
while misuse of
cannabis has
remained fairly
stable, ecstasy
misuse has
increased
Table 4a. Opiate as a Main Drug of Misuse for All Treatment Contacts treated in the NWHB, 1996-2000
Main Drug / Route 1996 1997 1998 1999 2000
of Administration N N N N N
Heroin 1 1 9 3 5
of whom:
inject 1 1 4 3 3
smoke 0 0 2 0 1
other route 0 0 3 0 1
Other Opiates 0 1 1 3 0
Total 1 2 10 6 5
Table 4b. Opiate as a Main Drug of Misuse for First Treatment Contacts treated in the NWHB, 
1996-2000
Main Drug / Route 1996 1997 1998 1999 2000
of Administration N N N N N
Heroin 0 1 0 1 0
of whom:
inject 0 1 0 1 0
smoke 0 0 0 0 0
other route 0 0 0 0 0
Other Opiates 0 0 1 2 0
Total 0 1 1 3 0
Table 5a. Secondary Drug of Misuse of All Treatment Contacts treated in the NWHB, 1996-2000 
Secondary Drug 1996 1997 1998 1999 2000
of Misuse N (%) N (%) N (%) N (%) N (%)
No second drug 2 (15) 4 (25) 12 (27) 6 (15) 19 (25)
Opiates 0 (0) 1 (6) 2 (4) 0 (0) 3 (4)
Cocaine 0 (0) 0 (0) 1 (2) 2 (5) 2 (3)
Ecstasy 0 (0) 2 (13) 10 (22) 8 (21) 19 (25)
Amphetamines 0 (0) 1 (6) 0 (0) 1 (3) 2 (3)
Benzodiazepines 1 (8) 0 (0) 0 (0) 1 (3) 0 (0)
Volatile Inhalants 0 (0) 0 (0) 1 (2) 1 (3) 0 (0)
Cannabis 4 (31) 4 (25) 12 (27) 11 (28) 22 (29)
Alcohol 4 (31) 3 (19) 6 (13) 9 (23) 6 (8)
Other substances 2 (15) 1 (6) 1 (2) 0 (0) 4 (5)
Total 13 17* 45 39 77
* Percentages based on valid N of 16
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Among new clients heroin use is practically non-existent with one person presenting in 1997 and one
person in 1999 (Table 4b).
Trends in secondary drug use indicate that polydrug use is prevalent, with at least three-quarters of all
contacts using more than one drug (Table 5a). Cannabis is the drug most likely to be involved in
polydrug use each year. Over the five-year period, there was an increase in ecstasy use – from none in
1996, to 25 percent in 2000 (Table 5a). The use of alcohol3 as a secondary drug decreased from 31
percent in 1996 to 8 percent in 2000.  
Clients are
likely to be
involved in
polydrug use
Trends among first contacts (new clients) were similar to those among all contacts, except in 1998 and
2000 when ecstasy use was very slightly higher than cannabis use among new clients (Table 5b).   
3 Alcohol may be included as a secondary drug of misuse in the NDTRS. It is NOT included as a main drug of misuse
Table 6a. Risk Behaviours of All Treatment Contacts treated in the NWHB, 1996-2000
Risk Behaviours 1996 1997 1998 1999 2000
Mean age of initial drug use (years) 22 17 16 16 16
Mean age 1st injected (years) 16 21 19 19 21
Ever Injected  N 1 3 8 5 6
of whom:
‘ever shared’  N 1 0 5 2 4
‘currently injecting’  N 0 1 2 2 1
‘currently sharing’  N 0 0 1 0 0
Table 6b. Risk Behaviours of First Treatment Contacts treated in the NWHB, 1996-2000
Risk Behaviours 1996 1997 1998 1999 2000
Mean age of initial drug use (years) 17 17 16 16 16
Mean age 1st injected (years) Na 21 16 17 23
Ever Injected  N 0 3 1 2 2
of whom:
‘ever shared’  N 0 0 0 0 1
‘currently injecting’  N 0 1 0 1 0
‘currently sharing’  N 0 0 0 0 0
Na: Not applicable
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Trends in risk behaviour associated with drug use are quite stable in the NWHB area. Over the five-year
period the mean age of initial drug use decreased from 22 years in 1996 to 17 years in 1997, and then
stabilised at 16 years of age between 1998 and 2000 (Table 6a). Injecting drug use is not presenting as a
problem in the NWHB: there was 1 client who ever injected in 1996 and 6 in 2000.      
Risk behaviour
Trends among new clients are similar to those of the overall group of all contacts (Table 6b).  
Table 5b. Secondary Drug of Misuse of First Treatment Contacts treated in the NWHB, 1996-2000
Secondary Drug 1996 1997 1998 1999 2000
of Misuse N (%) N (%) N (%) N (%) N (%)
No second drug 0 (0) 4 (29) 7 (24) 4 (15) 14 (23)
Opiates 0 (0) 0 (0) 0 (0) 0 (0) 2 (3)
Cocaine 0 (0) 0 (0) 0 (0) 1 (4) 1 (2)
Ecstasy 0 (0) 2 (14) 9 (31) 4 (15) 17 (28)
Amphetamines 0 (0) 1 (7) 0 (0) 1 (4) 1 (2)
Benzodiazepines 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Volatile Inhalants 0 (0) 0 (0) 1 (3) 1 (4) 0 (0)
Cannabis 3 (50) 4 (29) 8 (28) 9 (33) 16 (27)
Alcohol 1 (17) 2 (14) 3 (10) 7 (26) 5 (8)
Other substances 2 (33) 1 (7) 1 (3) 0 (0) 4 (7)
Total 6 14 29 27 60
Injecting drug
use is not a
problem in the
NWHB area
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Figure 1a. Trends in All Treatment Contact rates for 15 - 39 year olds by Health Board of 
Residence, 1996-2000*. Rates per 10,000 population **
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Figure 1b. Trends in First Treatment Contact rates for 15 - 39 year olds by Health Board of 
Residence, 1996-2000*. Rates per 10,000 population **
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* Trends for 1996-1999 only in the EHB due to incomplete returns for 2000
** Population figures for each health board are based on the Census for Population 1996, Central Statistics Office
* Trends for 1996-1999 only in the EHB due to incomplete returns for 2000
** Population figures for each health board are based on the Census for Population 1996, Central Statistics Office
Year
Figures 1a and 1b provide a comparison of the rates of treated drug misuse among residents in different health
board areas of Ireland for all and first treatment contacts respectively. As the majority of people treated for
problem drug use are in the 15-39 year age group, the rates were based on this age group of the population in
each health board area. It is immediately obvious that in the ERHA health board areas (formerly EHB) the rate is
much higher than in other regions of the country. However, there is not great variation in regional trends.  In all
cases the trend shows an increase in those presenting to drug treatment services (Figure 1a).  
Regional trends
There was an upward trend in first treatment contacts between 1996 and 2000 in all regions (Figure 1b).
Increased provision of services at individual health board level is of course a factor that must be borne in
mind when considering such trends. Where there are accessible drug user oriented services provided,
people are more likely to approach them. However, it would appear that the upward trends also indicate
a real increase in drug misuse.   
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